Posts

Showing posts with the label Bioanalytical Testing Services Market

Bioanalytical Testing Services Market Size, Demand, Business Challenges, Opportunities and Major Key Players 2023-2028

Image
IMARC Group, a leading market research company, has recently releases report titled “ Bioanalytical Testing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028. ” The study provides a detailed analysis of the industry, including the global bioanalytical testing services market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. How big is the bioanalytical testing services market? The global bioanalytical testing services market size reached US$ 2.8 Billion in 2022 . Looking forward, IMARC Group expects the market to reach US$ 5.1 Billion by 2028 , exhibiting a growth rate (CAGR) of 9.6% during 2023-2028 . Request to Get the Sample Report: https://www.imarcgroup.com/bioanalytical-testing-services-market/requestsample What are bioanalytical testing services? Bioanalytical testing services encompass the quantitative measurement of drug conce...

Bioanalytical Testing Services Market Size, Share, Key Players, Growth and Opportunity 2022-2027

Image
Bioanalytical testing refers to a branch of analytical chemistry that involves the quantitative measurement of drugs and metabolites present in multiple biological fluids, such as blood, plasma, serum, urine, or tissue extracts. It includes cell-based assays, in vitro or vivo virology testing, method development, optimization and validation, and immunogenicity as common service types. These testing methods ensure results that validate accuracy, precision, and stability. Consequently, bioanalytical testing services find extensive applications in pharmacology, bioavailability, bioequivalence, pharmacokinetic, and toxicological research. Market Trends:  The increasing demand for effective biopharmaceutical products and the growing acceptance of biosimilars and generics are majorly driving the bioanalytical testing services market growth . In line with this, the rising prevalence of chronic diseases, such as diabetes and cancer, coupled with the growing pre-clinical and clinical trials...